BTK and COVID-19: Given BTK’s role in innate immune signaling pathways, inhibitors of BTK are being investigated in treatment of rheumatoid arthritis (RA) (Di Paolo et al., 2011), and the 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection.